+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alpha Receptor Agonist"

Alpha Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Alpha Receptor Agonists are a class of drugs used to treat a variety of conditions related to the Central Nervous System (CNS). These drugs act on alpha receptors, which are found in the brain and other parts of the body. Alpha receptor agonists are used to treat conditions such as anxiety, depression, insomnia, and pain. They can also be used to treat conditions such as hypertension, glaucoma, and Parkinson's disease. Alpha receptor agonists work by stimulating the alpha receptors, which can help to reduce symptoms associated with the condition. Alpha receptor agonists are commonly prescribed as part of a comprehensive treatment plan for CNS disorders. They are generally considered to be safe and effective when used as directed. However, they can cause side effects such as drowsiness, dizziness, and dry mouth. The Alpha Receptor Agonist market is an important part of the CNS drug market. It is comprised of a variety of drugs, including benzodiazepines, barbiturates, and selective serotonin reuptake inhibitors (SSRIs). These drugs are used to treat a variety of conditions related to the CNS. Some companies in the Alpha Receptor Agonist market include Pfizer, GlaxoSmithKline, Merck, and Eli Lilly. These companies produce a variety of drugs that are used to treat CNS disorders. Show Less Read more